secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dare Bioscience, Inc. (DARE)
CIK:        0001401914
Form:       8-K
Filed at:   2025-02-14T23:59:59+00:00
Accession:  0001493152-25-006958
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Dare Bioscience receives Nasdaq delisting notice for failing to meet $35M minimum MVLS rule
--------------------------------------------------------------------------------

- On Feb 13, 2025, Nasdaq notified Dare Bioscience that its common stock is subject to delisting for failure to regain compliance with the Minimum MVLS Rule by Feb 10, 2025.
- The company will request a hearing before the Nasdaq Hearing Panel, which will stay the delisting pending the Panel's decision.
- Hearings typically scheduled 30-45 days after request; Panel decision expected within 30 days of hearing; no assurance of extension granted.
- Original deficiency notice received Aug 12, 2024; company had 180 days to regain compliance but failed to meet the $35M market value requirement.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401914/000149315225006958/0001493152-25-006958-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401914/000149315225006958/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-006958

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer